Clinic News

Latest in Cardiology

• Evaluation of Type 5 Long QT Syndrome
  What are the genetic features and clinical phenotypes associated with type 5 long QT syndrome (LQT5)?
• Attenuated Mitral Leaflet Enlargement and Ischemic Mitral Regurgitation
  Does myocardial infarction (MI) impair mitral leaflet growth seen among patients with aortic regurgitation (AR) with left ventricular (LV) dilation, and induce fibrotic changes in the mitral valve and tricuspid valve?
• Post-STEMI Remodeling and Outcome
  What is the impact of post-infarct left ventricular (LV) remodeling on outcomes in the current era of primary percutaneous coronary intervention (PCI) and optimal medical therapy? 
• Routine vs. Selective Cardiac Magnetic Resonance in Non-Ischemic Heart Failure
  The goal of the OUTSMART-HF trial was to assess the efficacy of routine versus selective cardiac magnetic resonance (CMR) in patients with nonischemic heart failure (HF).
• ACCEL Lite: Featured ACCEL Interview With David Moliterno and Daniel Thuijs
  In this interview, David Moliterno and Daniel Thuijs discuss the SYNTAX Extended Survival study: Ten-Year Survival after Coronary Artery Bypass Grafting versus Percutaneous Coronary Intervention.
• Implications of Abnormal Exercise ECG With Normal Stress Echo
  What are the clinical implications and prognostic significance of abnormal (positive) exercise electrocardiography (ECG) but normal stress echocardiography (Echo)?
• Specialized Atrial Fibrillation Clinic Improves Quality Metrics
  Is an atrial fibrillation (AF)–specific clinic associated with improved adherence to American College of Cardiology (ACC)/American Heart Association (AHA) clinical performance and quality measures for adults with AF or atrial flutter?
• Echo Phenotype and Prognosis in Transthyretin Cardiac Amyloidosis
  What are the structural and functional echocardiographic phenotypes across the spectrum of wild-type (wtATTR-CM) and hereditary (hATTR-CM) transthyretin cardiomyopathy, and the echocardiographic features predicting prognosis?
• Management of PE
  The incidence of venous thromboembolism (VTE), including pulmonary embolism (PE) and deep venous thromboembolism (DVT), in the United States is unclear because there is no national surveillance system.
• CV Toxicity and Mitochondrial Dysfunction: Why Younger Hearts Are at Risk
  Drug-induced cardiovascular toxicity is thought to be mediated by mitochondrial dysfunction. Mitophagy is a process of recovery through which damaged mitochondria are removed.